Press Release

Horizon Pharma Acquires Vidara Therapeutics and Enters Five-Year $300 Million Term Loan Facility

September 30, 2014

San Diego – September 30, 2014 – Cooley LLP announced today that it advised Horizon Pharma, Inc. on the completion of its acquisition of Vidara Therapeutics International plc. In connection with the acquisition, Horizon and Vidara have combined to form parent company Horizon Pharma plc, which is incorporated in Ireland. Concurrently with the acquisition, Horizon entered into a five-year $300 million term loan facility and related uncommitted facilities.

The acquisition further accelerates Horizon's transformation into a profitable specialty biopharmaceutical company and provides a strong operating and financial platform for future growth. Cooley announced its representation of Horizon in its $600 million acquisition of Vidara in March 2014. View the press release here.

About Cooley LLP

Cooley's attorneys solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and bet-the-company litigation, often where innovation meets the law.

Cooley has more than 750 lawyers across 11 offices in the United States and China.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.